Table 3 Pharmacological Management of Anxiety
Most frequently prescribed medication | Prognosis days-weeks | Prognosis months | |
|---|---|---|---|
n (%) | n (%) | ||
1st Line | ( n = 216) | ( n = 211 ) | |
Benzodiazepine (BZ) | 200 (93) | 99 (47) | |
Alone | 188 (87) | 78 (37) | |
Combined (with another drug class) | 12 (6) | 21 (10) | |
Where BZ specified: | (n = 147) | (n = 73) | |
Lorazepam | 127 (86) | 60 (8) | |
Diazepam | 11 (7) | 13 (18) | |
Midazolam | 8 (5) | 0 (0) | |
Antidepressant (AD) | 21 (10) | 127 (60) | |
Alone | 12 (6) | 107 (51) | |
Combined (with BZ) | 9 (4) | 20 (9) | |
Where AD specified: | (n = 17) | (n = 93) | |
Mirtazapine | 12 (71) | 35 (38) | |
Citalopram | 3 (18) | 50 (54) | |
Sertraline | 2 (12) | 6 (6) | |
Other Medications | |||
Haloperidol | 4 (2) | 2 (1) | |
Levomepromazine | 2 (1) | 0 (0) | |
Pregabalin | 0 (0) | 4 (2) | |
2nd Line | ( n = 142) | ( n = 124) | |
Benzodiazepine | 99 (70) | 57 (46) | |
Where BZ specified: | (n = 96) | (n = 49) | |
Midazolam | 46 (48) | 4 (8) | |
Diazepam | 31 (32) | 16 (33) | |
Lorazepam | 18 (19) | 29 (59) | |
Antidepressant | 26 (18) | 55 (44) | |
Where AD specified: | (n = 18) | (n = 41) | |
Mirtazapine | 9 (50) | 22 (54) | |
Amitriptyline | 4 (22) | 1 (2) | |
Citalopram | 3 (17) | 11 (27) | |
Sertraline | 1 (6) | 5 (12) | |
Other Medications | |||
Levomepromazine | 9 (6) | 3 (2) | |
Pregabalin | 2 (1) | 8 (6) | |
Morphine | 2 (1) | 3 (2) | |
Unspecified antipsychotic | 3 (2) | 0 (0) | |